Irena Ivnitski-Steele

Title: Irena Ivnitski-Steele: Innovator in Cancer Treatment

Introduction

Irena Ivnitski-Steele is a notable inventor based in Coral Springs, FL (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for cancer. Her innovative work focuses on selective efflux inhibitors that target cancer-associated transporter proteins.

Latest Patents

Ivnitski-Steele holds a patent for "Selective efflux inhibitors and related pharmaceutical compositions and methods of treatment." This invention provides pyrazolo[1,5-a]pyrimidine compounds that inhibit cancer-associated transporter proteins. The methods described in her patent aim to treat or prevent diseases mediated by these proteins. Notably, her compounds are selective toward ABCG2 over ABCB1, making them particularly effective against drug-resistant and multiple drug-resistant cancers.

Career Highlights

Throughout her career, Irena Ivnitski-Steele has worked with esteemed institutions such as Stc.unm and the University of Kansas Medical Center Research Institute. Her research has contributed to advancements in cancer treatment, showcasing her dedication to improving patient outcomes.

Collaborations

Ivnitski-Steele has collaborated with notable colleagues, including Richard Smith Larson and Larry A Sklar. These partnerships have furthered her research and development efforts in the pharmaceutical field.

Conclusion

Irena Ivnitski-Steele's innovative work in cancer treatment through selective efflux inhibitors highlights her significant impact on the pharmaceutical industry. Her contributions continue to pave the way for advancements in cancer therapies.